ERBB2 and breast carcinoma: For instance, in breast cancer, the presence of TILs within tumors has been shown to indicate an immunogenic character, with certain subtypes like triple-negative breast cancer (TNBC) and HER2-positive breast cancer demonstrating a higher number of TILs compared to hormone receptor-positive (HR+) subtypes (18).